Early diagnosis of fungal infection in immunocompromised patients

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue SUPPL. 1, 2008, Pages 3-6

  Barnes, Rosemary A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antigen detection; Aspergillus spp.; Candida spp.; PCR

Indexed keywords

ANTIFUNGAL AGENT;

DISEASE MANAGEMENT; DRUG EFFECT; EARLY DIAGNOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; MYCOSIS; REVIEW;

ANTIFUNGAL AGENTS; DISEASE MANAGEMENT; EARLY DIAGNOSIS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES;

EID: 41949095614     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm424     Document Type: Article

References (34)

1. Lamagni TL, Evans BG, Shigematsu M et al. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001; 126: 397-414.
2. Kibbler CC, Seaton S, Barnes RA et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24.
3. Blot SI, Vandewoude KH, Hoste EA et al. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2003; 113: 480-5.
4. Blot SI, Hoste EA, Vandewoude KH et al. Estimates of attributable mortality of systemic Candida infection in the ICU. J Crit Care 2003; 18: 130-1.
5. Sinha J, Barnes RA. Fungal infections in critical care: the appropriate use of antifungal agents. Brit J Intens Care Med 2003; 14: 89-98.
6. Upton A, Kirby KA, Carpenter P et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-40.
7. Cornillet A, Camua C, Nimubona S et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillo-sis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577-84.
8. Segal BH, Almyroudis NG, Battiwalla M et al. Prevention of invasive fungal infection. Clin Infect Dis 2007; 44: 402-9.
9. von Eiff M, Roos N, Schulten R et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1985; 62: 341-7.
10. Pizzo PA, Robichaud KJ, Gill FA et al. Empiric antibiotic and antifungal therapy for cancer-patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101-11.
11. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-72.
12. Ascioglu S, Rex JH, Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
13. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-40.
14. Musher B, Fredricks D, Leisenring W et al. Aspergillus antigen enzyme immunoassay and quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004; 42: 5517-22.
15. Buchheidt D, Hummel M, Schleiermacher D et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of IA in neutropenic cancer patients and haematological stem cell transplant recipients. Brit J Haematol 2004; 125: 196-202.
16. Costa C, Costa JM, Desterke C et al. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 2224-7.
17. Marr KA, Balajee SA, McLaughlin L et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-9.
18. De Pauw B, Walsh T, Donnelly JP et al. EORTC/BAMSG Consensus Revised Definitions Draft VI. http://www.aspergillus.org.uk/indexhome.htm?secure/diagnosis/index.php~main (3 August 2007, date last accessed).
19. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417-27
20. Adam O, Auperin A, Wilquin F et al. Treatment with piperacillin- tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917-20.
21. Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1!3) b-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654-9.
22. Pickering J, Sant H, Bowles C et al. Evaluation of a (1!3)-b-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957-62.
23. Donnelly JP. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 2006; 42: 487-9.
24. White PL, Barnes RA. Aspergillus PCR-platforms, strengths and weaknesses. Med Mycol 2006; 44: S191-8.
25. White PL, Barton R, Guiver M et al. A consensus on fungal polymerase chain reaction diagnosis? A United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagnost 2006; 8: 376-84.
26. Procop GW. Evaluation of molecular diagnostic assays for fungal infections. J Mol Diagnost 2006; 8: 297-8.
27. McCracken D, Barnes R, Poynton C et al. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. J Infect 2003; 47: 344-7.
28. White PL, Archer AE, Barnes RA. A comparison of non-culture based methods for the diagnosis of systemic fungal infections with an emphasis on invasive Candida infections. J Clin Microbiol 2005; 43: 2181-7.
29. White PL, Linton CJ, Perry MD et al. The evolution and evaluation of a PCR assay for the detection of invasive aspergillosis in haematology patients. Clin Infect Dis 2006; 42: 479-86.
30. Greene RE, Schlamm H, Oestmann J-W et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-9.
31. Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242-50.
32. Becker MJ, Lugtenburg EJ, Cornelissen JJ et al. Galactomannan detection in computerized tomography-based bronchoalveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Brit J Haematol 2003; 121: 448-57.
33. Hebart H, Klingspor L, Klingebiehl T et al. PCR-based liposomal amphotericin B treatment following allogeneic stem cell transplantation is a safe treatment strategy: preliminary results of a prospective study. Blood 2004; 104: 59A.
34. Cornely OA, Maertens J, Winston DJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Eng J Med 2007; 356: 348-59.